Tirzepatide
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
Eli Lilly · Phase 2 · Recruiting · Enrollment 1481
Participants reaching threshold, %
Source: Cited trial source. The denominator is the source figure, when it states one.
No selected arm reports a responder percent.
Show as table
| Arm | ≥5% | ≥10% | ≥15% | ≥20% |
|---|---|---|---|---|
| LY3305677 Obesity ISA OXA1 | n/r | n/r | n/r | n/r |
| LY3841136 Obesity ISA LAA1 | n/r | n/r | n/r | n/r |
| LY3841136 Obesity ISA LAA2 | n/r | n/r | n/r | n/r |
| LY3549492 Obesity ISA GN01 | n/r | n/r | n/r | n/r |
| LY3549492 Obesity ISA GN02 | n/r | n/r | n/r | n/r |
| Obesity ISA MC01 | n/r | n/r | n/r | n/r |
Not shown
- LY3305677 Obesity ISA OXA1: endpoint not reported
- LY3841136 Obesity ISA LAA1: endpoint not reported
- LY3841136 Obesity ISA LAA2: endpoint not reported
- LY3549492 Obesity ISA GN01: endpoint not reported
- LY3549492 Obesity ISA GN02: endpoint not reported
- Obesity ISA MC01: endpoint not reported